
FDA Approves PET Imaging Agent for Prostate Cancer
The PET imaging agent, TXL007-CDx, a kit for the preparation of gallium-68 gozetotide (68Ga) injection for patients with prostate cancer has been approved by the FDA, according to a press release from Telix.1 TLX007-CDx is indicated for PET scanning of …